2015
DOI: 10.1016/j.jacc.2014.12.036
|View full text |Cite|
|
Sign up to set email alerts
|

Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

Abstract: The lack of consistent definitions and nomenclature across clinical trials of novel devices, drugs, or biologics poses a significant barrier to accrual of knowledge in and across peripheral artery disease therapies and technologies. Recognizing this problem, the Peripheral Academic Research Consortium, together with the U.S. Food and Drug Administration and the Japanese Pharmaceuticals and Medical Devices Agency, has developed a series of pragmatic consensus definitions for patients being treated for periphera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
90
0
4

Year Published

2015
2015
2018
2018

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 302 publications
(115 citation statements)
references
References 36 publications
0
90
0
4
Order By: Relevance
“…The high mortality of HD may be due to the plenty of vascular complications, such as vascular calcification [4] and atherosclerosis [5]. Peripheral arterial disease (PAD) is a systemic vascular disorder involving the aorta, iliac, and lower extremity arteries usually secondary to atherosclerosis [6, 7]. It is diagnosed by ankle-brachial/arm blood pressure index (ABI, or AAI, or ABPI) measurement and clinical assessment.…”
Section: Introductionmentioning
confidence: 99%
“…The high mortality of HD may be due to the plenty of vascular complications, such as vascular calcification [4] and atherosclerosis [5]. Peripheral arterial disease (PAD) is a systemic vascular disorder involving the aorta, iliac, and lower extremity arteries usually secondary to atherosclerosis [6, 7]. It is diagnosed by ankle-brachial/arm blood pressure index (ABI, or AAI, or ABPI) measurement and clinical assessment.…”
Section: Introductionmentioning
confidence: 99%
“…Two or three runoff tibial trunks were evinced in 84% cases, while one or none permeable vessel were found in 23 (16%) of limbs. Moderate-to-severe arterial calcifications [12] were present in 55 (38%) cases ( Table 3).…”
Section: Study Design and Cohortmentioning
confidence: 99%
“…The additional hemodynamic involvement of the common femoral artery (CFA) in more complex infrainguinal occlusive presentations [2] [3] [12] was however less studied in the contemporary literature [3]. While most of these patients are either treated by femoro-popliteal bypass [2] [3] [12]- [14], or by way of CFA endarterectomy [15] [16], new reports analyzing specific endovascular recanalization techniques indicate comparable patency rates at one year [17].…”
Section: Introductionmentioning
confidence: 99%
“…Ankle pressure criteria range from less than 40–70mmHg, toe pressures less than 30–50mmHg, TcO2 less than 20–40mmHg. Higher cutpoints are often used for tissue loss on the assumption that greater perfusion is required for wound healing, but expert consensus on these hemodynamic criteria differs between guidelines 2, 47 . The original definitions were designed to standardize entry criteria for clinical trials of CLI in patients without diabetes to permit comparisons across studies 4, 6 , or to assess the likelihood of wound healing 8 .…”
Section: Definitionsmentioning
confidence: 99%
“…More recently, several proposals for endpoints important in CLI have converged on limb salvage (avoiding a major amputation), and the need for major re-intervention (a new bypass graft, or thrombolysis of graft or treated segment) 4, 7, 51 . As a result of these developments, the NIH sponsored the BEST-CLI study - a new randomized trial of open surgery versus endovascular revascularization in CLI 52 .…”
Section: Open Surgical Revascularizationmentioning
confidence: 99%